Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 12/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810047 | 0.89 | PLA2G4B (0.56) | PLA2G4BGAAL3MBTL1 | |
| SCHEMBL10361085 | 0.84 | HDAC1 (0.65) | GAAL3MBTL1 | |
| SCHEMBL15849204 | 0.83 | TSHR (0.71) | PLA2G4BGAAALOX15L3MBTL1PLA2G4A | |
| SCHEMBL28881844 | 0.83 | TSHR (0.71) | PLA2G4BGAAALOX15L3MBTL1PLA2G4A | |
| SCHEMBL16156097 | 0.83 | TSHR (0.71) | PLA2G4BGAAALOX15L3MBTL1PLA2G4A | |
| SCHEMBL14683447 | 0.83 | TSHR (0.71) | PLA2G4BGAAALOX15L3MBTL1PLA2G4A | |
| SCHEMBL16156094 | 0.83 | TSHR (0.71) | PLA2G4BGAAALOX15L3MBTL1PLA2G4A | |
| SCHEMBL24935937 | 0.83 | GAA (0.58) | PPARDGAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL11842813 | 0.83 | PLA2G4B (0.76) | PLA2G4BPLA2G4A | |
| SCHEMBL9163844 | 0.83 | PLA2G4B (0.76) | PLA2G4BPLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902319-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2010-05-06 | — | — | US | disclosed |
| US-7671168-B2 | Unsymmetrical aromatic ether diacids and absorbable polymers therefrom | BEZWADA BIOMEDICAL, LLC (US) | 2010-03-02 | — | — | US | disclosed |
| US-20070141113-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | BEZWADA BIOMEDICAL, LLC (US) | 2007-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113592-A1 | UNSYMMETRICAL AROMATIC ETHER DIACIDS AND ABSORBABLE POLYMERS THEREFROM | DDT, ACMSD, HPD | PLA2G4B 4319/4885PPARD 626/4885GAA 2081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.